NCT05980481 2025-09-29A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric CancerRemeGen Co., Ltd.Phase 2/3 Active not recruiting201 enrolled
NCT06221748 2024-04-03DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line TherapyRemeGen Co., Ltd.Phase 2/3 Recruiting90 enrolled